Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Antibody that clears B-cells — for lymphoma and autoimmune disease. | Chemotherapy that also treats severe autoimmune disease. |
| Body system | Cancer | Cancer |
| Drug class | Targeted antibodies | Alkylating agents |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Non-Hodgkin lymphoma, Chronic lymphocytic leukaemia, Rheumatoid arthritis, ANCA vasculitis, Pemphigus | Lymphoma, Breast cancer, Leukaemia, Severe lupus and vasculitis, Before stem cell transplants |
| How it works | Removes a type of immune cell involved in lymphoma and some autoimmune diseases. | Damages DNA so dividing cells die. |
| Starts working | — | — |
| Half-life | About 3 weeks | — |
| Typical adult dose | Lymphoma: 375 mg/m² per cycle. Rheumatoid arthritis: 1 g twice, 2 weeks apart. | Varies widely by condition and regimen. |
| Forms | IV infusion, Subcutaneous injection | IV infusion, Tablet |
| Common side effects | Infusion reactions (first dose), Infections, Low white cells | Nausea, Hair loss, Low blood counts |
| Serious side effects | Hepatitis B reactivation, PML (rare brain infection), Severe infusion reactions | Bleeding from the bladder, Infertility, Secondary cancers, Infections |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Usually avoidedContraception for 12 months after. | Usually avoidedCauses birth defects. |
| Breastfeeding | — | — |
| In use since | 1997 | 1959 |
| Brand names | United States: Rituxan, Truxima, RuxienceUnited Kingdom: MabThera, Truxima, RixathonIndia: Reditux, Mabtas | United States: Cytoxan (historic)United Kingdom: CyclophosphamideIndia: Endoxan, Cyclomide |
| Legal status | — | — |
| ATC code | L01FA01 | L01AA01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker